Brief: NeuroOne Provides Progress Update on FDA 510(k) Submission for OneRF Ablation System
Nov 7 (Reuters) - Neuroone Medical Technologies Corp
NMTC.O :
* NEUROONE® PROVIDES PROGRESS UPDATE ON FDA 510(K)
SUBMISSION FOR
ONERF™ ABLATION SYSTEM
* NEUROONE MEDICAL TECHNOLOGIES CORP - FEEDBACK FROM
RESPONSES TO
FDA ANTICIPATED IN 30 DAYS
* NEUROONE MEDICAL TECHNOLOGIES CORP - COMMERCIALIZATION
REMAINS
ON TRACK IN FIRST HALF OF 2024 PENDING FDA CLEARANCE
Source text for Eikon: ID:nGNX4T1ypF
Further company coverage: NMTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroone Medical Technologies
See all newsBrief: Neuroone Medical Technologies Corp - Announces Successful Robotic-Assisted Drug Delivery Using Stereoced Platform - SEC Filing
NeuroOne Medical Technologies Corp reports results for the quarter ended June 30 - Earnings Summary
NeuroOne Medical Technologies Corp expected to post a loss of 22 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings
NASDAQ RESUMED AT 09:00 AM